RemeGen is a Chinese biopharmaceutical company based in Yantai that discovers, develops and commercialises biologic medicines. It focuses on antibody-drug conjugates and fusion proteins aimed at autoimmune diseases and cancer. Its products include a fusion protein for systemic lupus erythematosus and an antibody-drug conjugate for certain solid tumours. The company serves patients and healthcare providers in China and works with partners abroad to develop and market its therapies.
RemeGen Co. Ltd. A trades under the code 688331 on the Shanghai Stock Exchange in China, with its price quoted in Chinese yuan (CNY). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #875 of 2278 on the Shanghai Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for China yet.
TrendFair
64/100
Mixed trend against its averages.
See the numbers →
Above 200-day average-12.8%
From 52-week high-34.0%
MomentumWeak
42/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-18.8%
6-month return-25.0%
12-month, skipping last month43.1%
Stability (higher is calmer)Weak
41/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)66.8%
Worst drawdown, 1 year (smaller is calmer)-36.8%
LiquidityStrong
90/100
Trades actively.
See the numbers →
Avg daily value traded825.03M CNY
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for China when fundamentals data for this market is added. All China stocks.
52-wk range 75.03 – 157.80Daily closes, split-adjusted
Signals
50-day average118.10
200-day average115.99
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)5.65
Technical summary
Daily
Strongly bearish
1 bullish · 4 neutral · 11 bearish
Weekly
Bearish
3 bullish · 1 neutral · 8 bearish
Monthly
Bullish
5 bullish · 1 neutral · 2 bearish
Moving averages (daily)
SMA 10
101.1
Bullish
EMA 10
102.3
Bearish
SMA 20
109.3
Bearish
EMA 20
106.8
Bearish
SMA 50
118.1
Bearish
EMA 50
113.9
Bearish
SMA 100
118.9
Bearish
EMA 100
116.6
Bearish
SMA 200
116.0
Bearish
EMA 200
111.9
Bearish
Oscillators (daily)
RSI (14)
39.78
Neutral
MACD (12, 26)
-5.63
Bearish
Momentum (12)
-13.78
Bearish
Stochastic %K (14)
27.96
Neutral
Williams %R (14)
-72.04
Neutral
CCI (20)
-84.16
Neutral
Pivot points (classic, last session)
S3
87.90
S2
90.78
S1
95.98
Pivot
98.86
R1
104.1
R2
106.9
R3
112.1
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in CNY. Educational only, not financial advice.
